Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques
- 31 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 238, 115834
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Identification and characterization of related substances in pomalidomide by hyphenated LC–MS techniquesJournal of Pharmaceutical and Biomedical Analysis, 2015
- Enantioselective Synthesis of ((1R,2R)-Cyclohexane-1,2-diyl)bis(methylene)dimethanesulfonate, a Lurasidone Hydrochloride IntermediateSynthetic Communications, 2015
- Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2015
- The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra‐high performance liquid chromatography ‐ tandem mass spectrometryDrug Testing and Analysis, 2014
- Forced degradation and impurity profiling: Recent trends in analytical perspectivesJournal of Pharmaceutical and Biomedical Analysis, 2013
- The preclinical profile of lurasidone: clinical relevance for the treatment of schizophreniaExpert Opinion on Drug Discovery, 2013
- A Sensitive and Selective LC-MS Method for the Determination of Lurasidone in Rat Plasma, Bile, and UrineChromatographia, 2012
- Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in ratsXenobiotica, 2011
- Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high‐performance liquid chromatography with tandem mass spectrometryBiomedical Chromatography, 2011
- Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2010